PROFUND ADVISORS LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 206 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$312,146
-1.5%
11,457
-19.6%
0.02%0.0%
Q2 2023$317,040
-2.5%
14,249
-5.1%
0.02%
-15.0%
Q1 2023$325,138
+29.5%
15,011
+21.4%
0.02%
+25.0%
Q4 2022$251,052
-24.2%
12,361
-4.3%
0.02%
-33.3%
Q3 2022$331,000
+0.9%
12,914
-6.4%
0.02%
+14.3%
Q2 2022$328,000
-6.3%
13,794
-11.3%
0.02%
+40.0%
Q1 2022$350,000
+14.4%
15,554
+0.6%
0.02%
+50.0%
Q4 2021$306,000
-5.6%
15,455
-6.2%
0.01%
-9.1%
Q3 2021$324,000
-22.3%
16,485
-12.8%
0.01%
-21.4%
Q2 2021$417,000
-1.7%
18,902
+6.1%
0.01%
-12.5%
Q1 2021$424,000
-16.2%
17,819
-7.9%
0.02%
-27.3%
Q4 2020$506,000
+86.0%
19,345
+23.9%
0.02%
+57.1%
Q3 2020$272,000
-3.9%
15,615
-7.3%
0.01%
-12.5%
Q2 2020$283,000
+67.5%
16,851
+18.8%
0.02%
+23.1%
Q1 2020$169,000
-20.3%
14,181
-19.2%
0.01%
+44.4%
Q4 2019$212,000
-8.6%
17,552
+7.0%
0.01%
-25.0%
Q3 2019$232,000
+16.0%
16,399
-8.8%
0.01%
+33.3%
Q2 2019$200,000
-11.1%
17,978
-6.3%
0.01%
-18.2%
Q1 2019$225,000
-41.9%
19,197
-33.7%
0.01%
-54.2%
Q4 2018$387,000
-36.5%
28,962
-33.4%
0.02%
+4.3%
Q3 2018$609,000
+82.3%
43,464
+104.9%
0.02%
+76.9%
Q2 2018$334,000
+5.0%
21,216
+9.8%
0.01%0.0%
Q1 2018$318,000
+23.7%
19,331
+36.0%
0.01%
+30.0%
Q4 2017$257,000
+484.1%
14,217
+39.4%
0.01%
+400.0%
Q1 2014$44,00010,2000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 5,188,417$85,349,0007.80%
TANAKA CAPITAL MANAGEMENT INC 144,602$2,379,0005.69%
INGALLS & SNYDER LLC 6,817,540$112,149,0005.47%
NEXTHERA CAPITAL LP 1,045,196$17,193,0002.83%
Timpani Capital Management LLC 245,279$4,035,0001.41%
S&T BANK/PA 426,257$7,012,0001.25%
SHAKER INVESTMENTS LLC/OH 107,670$1,771,0001.10%
ESSEX INVESTMENT MANAGEMENT CO LLC 434,624$7,150,0000.94%
AMI ASSET MANAGEMENT CORP 709,300$11,668,0000.83%
Birchview Capital, LP 75,500$1,242,0000.82%
View complete list of CORCEPT THERAPEUTICS INC shareholders